Rang	Name	Position
1	Mr. Philip P. Boudreau	CFO & Executive VP of Finance
2	Mr. Daniel Gesua Sive Salvadori	Executive VP and Group President of Established Pharmaceuticals & Nutritional Products
3	Mr. Christopher J. Scoggins	Executive Vice President of Diabetes Care
4	Ms. Lisa D. Earnhardt	Executive VP & Group President of Medical Devices
5	Ms. Sabina Ewing	Senior VP of Business & Technology Services and Chief Information Officer
6	Mr. Michael Comilla	Vice President of Investor Relations.
7	Erica L. Battaglia	VP and Chief Ethics & Compliance Officer
8	Ms. Elizabeth C. Cushman	Executive VP, General Counsel & Secretary
9	Ms. Melissa Brotz	Senior Vice President of Global Marketing & External Affairs
10	Ms. Mary K. Moreland	Executive Vice President of Human Resources

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	10,08%	18,96 Mrd. USD
2	BlackRock Inc	8,36%	15,73 Mrd. USD
3	Vanguard Capital Management, LLC	6,48%	12,20 Mrd. USD
4	State Street Corp	4,57%	8,59 Mrd. USD
5	Capital Research Global Investors	2,86%	5,38 Mrd. USD
6	Vanguard Portfolio Management, LLC	2,75%	5,18 Mrd. USD
7	Charles Schwab Investment Management Inc	2,61%	4,91 Mrd. USD
8	Geode Capital Management, LLC	2,25%	4,23 Mrd. USD
9	Capital Research & Mgmt Co - Division 3	2,15%	4,05 Mrd. USD
10	Morgan Stanley - Brokerage Accounts	1,73%	3,25 Mrd. USD
11	Wellington Management Company LLP	1,55%	2,92 Mrd. USD
12	JPMorgan Chase & Co	1,54%	2,89 Mrd. USD
13	NORGES BANK	1,35%	2,53 Mrd. USD
14	Franklin Resources Inc	1,15%	2,16 Mrd. USD
15	Northern Trust Corp	1,11%	2,10 Mrd. USD
16	Bank of America Corp	1,11%	2,08 Mrd. USD
17	T. Rowe Price Associates, Inc.	0,99%	1,87 Mrd. USD
18	Wells Fargo & Co	0,91%	1,72 Mrd. USD
19	Massachusetts Financial Services Company	0,89%	1,67 Mrd. USD
20	The Goldman Sachs Group Inc	0,83%	1,57 Mrd. USD